A detailed history of Locust Wood Capital Advisers, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Locust Wood Capital Advisers, LLC holds 182,700 shares of ABT stock, worth $21.3 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
182,700
Previous 232,300 21.35%
Holding current value
$21.3 Million
Previous $24.1 Million 13.71%
% of portfolio
0.82%
Previous 1.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $15.2 Million - $18 Million
-151,973 Reduced 15.89%
804,480 $91.7 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $2.28 Million - $2.55 Million
22,673 Added 2.43%
956,453 $99.4 Million
Q1 2024

May 08, 2024

SELL
$109.52 - $120.96 $11.5 Million - $12.7 Million
-105,084 Reduced 10.12%
933,780 $106 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $8.45 Million - $10.3 Million
93,701 Added 9.91%
1,038,864 $114 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $28 Million - $33.6 Million
293,479 Added 45.03%
945,163 $91.5 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $5.41 Million - $6.03 Million
53,709 Added 8.98%
651,684 $71 Million
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $28.1 Million - $33 Million
289,723 Added 93.99%
597,975 $60.6 Million
Q4 2022

Jan 30, 2023

SELL
$95.06 - $111.52 $11.5 Million - $13.5 Million
-121,475 Reduced 28.27%
308,252 $33.8 Million
Q3 2022

Nov 01, 2022

BUY
$96.76 - $112.03 $1.49 Million - $1.73 Million
15,408 Added 3.72%
429,727 $41.6 Million
Q2 2022

Jul 20, 2022

BUY
$102.07 - $123.37 $12.8 Million - $15.4 Million
124,936 Added 43.17%
414,319 $45 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $10.8 Million - $13.2 Million
-94,702 Reduced 24.66%
289,383 $34.3 Million
Q4 2021

Jan 24, 2022

BUY
$115.53 - $141.46 $419,373 - $513,499
3,630 Added 0.95%
384,085 $54.1 Million
Q3 2021

Oct 20, 2021

BUY
$116.66 - $129.06 $365,379 - $404,215
3,132 Added 0.83%
380,455 $44.9 Million
Q2 2021

Jul 26, 2021

BUY
$105.79 - $124.53 $10.1 Million - $11.9 Million
95,377 Added 33.83%
377,323 $43.7 Million
Q1 2021

Apr 22, 2021

BUY
$108.84 - $128.23 $5.27 Million - $6.21 Million
48,436 Added 20.74%
281,946 $33.8 Million
Q4 2020

Jan 25, 2021

BUY
$105.0 - $114.42 $4.76 Million - $5.18 Million
45,310 Added 24.08%
233,510 $25.6 Million
Q3 2020

Oct 21, 2020

SELL
$91.64 - $111.29 $2.87 Million - $3.48 Million
-31,305 Reduced 14.26%
188,200 $20.5 Million
Q2 2020

Jul 21, 2020

SELL
$76.57 - $98.0 $3.09 Million - $3.96 Million
-40,411 Reduced 15.55%
219,505 $20.1 Million
Q1 2020

May 05, 2020

SELL
$62.82 - $91.86 $1.43 Million - $2.09 Million
-22,780 Reduced 8.06%
259,916 $20.5 Million
Q4 2019

Jan 28, 2020

SELL
$78.51 - $87.4 $13.9 Million - $15.4 Million
-176,600 Reduced 38.45%
282,696 $24.6 Million
Q3 2019

Oct 22, 2019

SELL
$81.84 - $88.74 $8.59 Million - $9.31 Million
-104,930 Reduced 18.6%
459,296 $38.4 Million
Q2 2019

Jul 24, 2019

SELL
$72.88 - $85.0 $11.5 Million - $13.4 Million
-157,940 Reduced 21.87%
564,226 $47.5 Million
Q1 2019

Apr 16, 2019

SELL
$66.22 - $80.06 $4.1 Million - $4.96 Million
-61,980 Reduced 7.9%
722,166 $57.7 Million
Q4 2018

Feb 01, 2019

BUY
$65.56 - $74.27 $7.66 Million - $8.68 Million
116,885 Added 17.52%
784,146 $56.7 Million
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $9.38 Million - $11.3 Million
-154,333 Reduced 18.78%
667,261 $49 Million
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $4.93 Million - $5.44 Million
-85,612 Reduced 9.44%
821,594 $50.1 Million
Q1 2018

Apr 18, 2018

BUY
$56.27 - $63.62 $5.56 Million - $6.28 Million
98,750 Added 12.21%
907,206 $54.4 Million
Q4 2017

Jan 30, 2018

SELL
$53.68 - $57.47 $69,247 - $74,136
-1,290 Reduced 0.16%
808,456 $46.1 Million
Q3 2017

Oct 18, 2017

BUY
$48.06 - $53.64 $38.9 Million - $43.4 Million
809,746
809,746 $43.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Locust Wood Capital Advisers, LLC Portfolio

Follow Locust Wood Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Locust Wood Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Locust Wood Capital Advisers, LLC with notifications on news.